Baloxavir Impurity 74, identified by its CAS number 2136287-69-7, is a chemical compound associated with the antiviral agent Baloxavir marboxil, which is used for the treatment of influenza. While specific details about Baloxavir Impurity 74 may not be widely documented, impurities in pharmaceutical compounds typically arise during the synthesis process and can affect the efficacy and safety of the final product. Characteristics of such impurities often include their molecular structure, solubility, stability, and potential biological activity. Impurities are generally characterized using techniques such as chromatography, mass spectrometry, and nuclear magnetic resonance (NMR) spectroscopy. Understanding the properties of impurities like Baloxavir Impurity 74 is crucial for quality control in drug manufacturing, as they can influence the pharmacokinetics and pharmacodynamics of the active pharmaceutical ingredient. Regulatory agencies require thorough characterization and quantification of impurities to ensure the safety and effectiveness of pharmaceutical products.

Baloxavir Impurity 74

2136287-69-7: Baloxavir Impurity 74, identified by its CAS number 2136287-69-7, is a chemical compound associated with the antiviral agent Baloxavir marboxil, which is used for the treatment of influenza. While specific details about Baloxavir Impurity 74 may not be widely documented, impurities in pharmaceutical compounds typically arise during the synthesis process and can affect the efficacy and safety of the final product. Characteristics of such impurities often include their molecular structure, solubility, stability, and potential biological activity. Impurities are generally characterized using techniques such as chromatography, mass spectrometry, and nuclear magnetic resonance (NMR) spectroscopy. Understanding the properties of impurities like Baloxavir Impurity 74 is crucial for quality control in drug manufacturing, as they can influence the pharmacokinetics and pharmacodynamics of the active pharmaceutical ingredient. Regulatory agencies require thorough characterization and quantification of impurities to ensure the safety and effectiveness of pharmaceutical products.

CAS 2136287-69-7

Baloxavir Impurity 74

Baloxavir Marboxil Impurity 26

Ref: 4Z-B-192035

Baloxavir Impurity 4

Ref: ST-EA-CP-B108004